Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Journal of Surgical Research|November 21, 2013
Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomasRoberto Patuzzo, Andrea Maurichi, Tiziana Camerini, et al.
Cancer Research|September 24, 2010
Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanomaAndrea Anichini, Alessandra Molla, Claudia Vegetti, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 13, 2024
Local Recurrence and Survival in Patients With Melanoma >2 mm in Thickness at Difficult Sites Treated With 1-cm Versus 2-cm MarginsAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.
JAMA Dermatology|April 12, 2023
Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical StructuresAndrea Maurichi, Francesco Barretta, Roberto Patuzzo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic studySandro Pasquali, Simone Mocellin, Nicola Mozzillo, et al.
Cancers|May 27, 2026
New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of MelanomaAndrea Spagnoletti, Lorenza Di Guardo, Alice Indini, et al.
JAMA Surgery|May 9, 2014
Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanomaCarlo Riccardo Rossi, Nicola Mozzillo, Andrea Maurichi, et al.
Cancer Immunology, Immunotherapy : CII|May 15, 2015
Intralesional administration of L19-IL2/L19-TNF in stage III or stage IVM1a melanoma patients: results of a phase II studyRiccardo Danielli, Roberto Patuzzo, Anna Maria Di Giacomo, et al.
Stem Cells (Dayton, Ohio)|June 15, 2016
Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating CellsAlessandra Tuccitto, Marcella Tazzari, Valeria Beretta, et al.
Pageof 5